Cellectis S.A.
ALCLS.PA · PAR
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €151 | €130 | €152 |
| - Cash | €52 | €60 | €128 | €143 |
| + Debt | €29 | €95 | €92 | €91 |
| Enterprise Value | – | €186 | €94 | €100 |
| Revenue | €35 | €17 | €11 | €13 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Gross Profit | €33 | €14 | €9 | €13 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| EBITDA | €8 | -€17 | -€11 | €14 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |
| Net Income | €1 | -€24 | -€18 | €6 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.066 |
| % Growth | 102.5% | -33.3% | -373.1% | – |
| Operating Cash Flow | -€2 | -€10 | -€17 | -€0 |
| Capital Expenditures | -€1 | -€0 | -€0 | -€2 |
| Free Cash Flow | -€3 | -€11 | -€18 | -€2 |